Showing 6 results for Researcher: Roy Copping
February 28, 2024
6 MIN READ
Two different teams that included Oak Ridge National Laboratory employees were honored Feb. 20 with Secretary’s Honor Achievement Awards from the Department of Energy. This is DOE's highest form of employee recognition.
November 17, 2021
6 MIN READ
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
August 26, 2021
2 MIN READ
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
August 2, 2021
1 MIN READ
An Oak Ridge National Laboratory researcher has invented a version of an isotope-separating device that can withstand extreme environments, including radiation and chemical solvents.
June 2, 2020
1 MIN READ
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
May 31, 2018
4 MIN READ
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.